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Background: Granule products produced from medicinal herbs are gaining popularity. However, there have been few
studies comparing the quality or efficacy of granules with those of herbal formulations. This study aims to compare
commercially available notoginseng (Sanqi in Chinese) in both raw and granule forms by thin layer chromatography (TLC)
and ultra-performance liquid chromatography with photodiode array detection (UPLC-PDA) using multivariate analysis.
Methods: Aqueous extracts of the raw herb (collected from six different sources in China) and granule products
(purchased in China, Taiwan and Australia) were re-extracted with methanol to remove water-soluble excipients.
Five compounds (ginsenosides Rg1, Rg2, Rd and Rb1 and notoginsenoside NR1) in the methanolic extracts were
quantified by TLC and UPLC-PDA. Multivariate statistical analysis using hierarchical component analysis (HCA)
and principal component analysis (PCA) was used to determine the similarities between the granule products and raw
herbs. A 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay was used to measure the antioxidant capacities
of the extracts.
Results: HCA and PCA of the TLC analysis clustered the granule products into one group. By UPLC analysis, the raw herbs
and two of the granule products (G7 and G12) were allocated into Group 1 and the rest of the granule products into
Group 2. The contents of the five marker compounds in Group 1 were higher than Group 2 and also exhibited stronger
ABTS activity (P= 0.005). By Pearson correlation, the contents of the five compounds in the samples were positively and
significantly correlated to their antioxidant activities.
Conclusions: UPLC was more efficient than TLC for the simultaneous determination of the five major compounds in Sanqi
products in terms of linearity, higher sensitivity and repeatability. The statistical analysis of the samples by HCA and PCA
revealed that the contents of the marker compounds were significantly higher in the raw herb group than the granule
group.Background
The use of herbal preparations as pharmaceutical pro-
ducts is considered convenient, portable and consistent
[1]. Granule products of herbal preparations are increa-
singly popular among consumers. Granule products for
use in traditional Chinese medicine are prepared by con-
centrating a herbal extract to a dry powder, and then* Correspondence: k.chan@uws.edu.au
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soluble fibres [1]. As with pharmaceutical preparations,
these products must meet minimum quality, safety and ef-
ficacy requirements, especially testing the pharmacological
efficacy of granule products against decoctions prepared
by boiling medicinal herbs in water. Non-standardised
manufacturing and quality control procedures would in-
advertently introduce clinical inconsistency in dosages for
consumers. Currently, there are no established regulatory
guidelines for the standardisation of granule products, and
few studies have compared the granule’s chemical profile
to that of the raw material. Thus, the quality assurance/icle distributed under the terms of the Creative Commons Attribution License
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ture development.
Thin layer chromatography (TLC) and high perform-
ance liquid chromatography are standard industry me-
thods for the quality control of herbal products [2–4].
TLC has been used extensively in industry because of its
simplicity, low cost and versatility for simultaneous ana-
lysis of multiple samples [5]. In the last decade, ultra-
performance liquid chromatography (UPLC) has become
the preferred method for the analysis of herbal products
because of its sensitivity and high resolution for the quan-
tification of active components [5–7].
Multivariate statistical analyses such as hierarchical
component analysis (HCA) and principal component
analysis (PCA) are employed to compare multiple sam-
ples [6]. HCA classifies samples into clusters according
to their similarities or differences. PCA uses a linear
mathematical algorithm to derive principal components
(PCs), and assesses how certain combinations of key fac-
tors account for differences between samples [8].
Notoginseng (Sanqi) is the root and rhizome of Panax
notoginseng (Burk.) F. H. Chen. There is a large market
for notoginseng granules in China, with data from the
China Food and Drug Administration showing more
than 50 granule products are currently manufactured
[9]. These products are also widely available in Australia
and other Western countries. Therefore, Sanqi was cho-
sen as an example for the quality control of granule
products. Sanqi is commonly used for the management
of cardiovascular complications [10] because of its anti-
oxidant, antiplatelet [11], haemostatic [12] and fibri-
nolytic activity [13]. The plant-based antioxidant effects
were involved in the prevention and treatment of cardio-
vascular diseases [14, 15]. The antioxidant activities of
the extracts of raw notoginseng and its saponin com-
pounds have been well studied [10]. The antioxidant
capacities of notoginseng products can be measured
using the simple 2,2′-azino-bis(3-ethylbenzothiazoline-
6-sulfonic acid (ABTS) assay, and the results used to as-
sess the claimed bioactivity. However, no studies have
assessed the antioxidant effects of granule formulations
in comparison with the raw herb.
This study aims to compare commercially available
notoginseng (Sanqi) in both raw and granule forms by
TLC and UPLC-photodiode array (PDA) using multivari-
ate analysis. In this study, the ginsenosides Rg1, Rg2, Rd
and Rb1 and notoginseng R1 (NR1) (Additional file 1)
were qualitatively and quantitatively evaluated in raw
notoginseng and granule products using TLC. The results
were compared with those from UPLC with PDA detec-
tion, and the quantitative data were analysed by HCA and
PCA. The ABTS assay was used to determine the anti-
oxidant capacities of the samples and examine any correl-
ation of this to the amount of the marker compounds.The results from this in vitro chemical assay, when corre-
lated to the chemical profiles of the samples, will provide
further information about the quality of the notoginseng
products.
Methods
Chemicals and plant materials
Raw notoginseng (R1-R6) was collected from six different
sources in China and twelve herbal granule products
(G1-G12) were purchased in China, Taiwan and Australia
(Additional file 2). The raw herb samples were authenti-
cated by Professor Si-bao Chen (Department of Applied
Biology and Chemical Technology, Hong Kong Polytechnic
University, Hong Kong, China) according to the Hong
Kong Materia Medica Standards and Pharmacopoeia of
the People’s Republic of China 2010 (PPRC). A voucher
specimen of each sample was deposited in the National
Institute of Complementary Medicine (NICM), University
of Western Sydney. Product names have been omitted due
to the absence of consent for disclosure. The five marker
compounds, notoginseng NR1 and ginsenosides Rg1, Rb1,
Rd and Rg2, were purchased from Chengdu Biopurify
Phytochemicals Ltd. (Chengdu, China; purity >98 %). HPLC
grade acetonitrile and methanol were purchased from
Thermo Fisher Scientific (Waltham, MA, USA). Analytical
grade ethyl acetate, sulfuric acid and chloroform were pur-
chased from Ajax Finechem (Sydney, Australia).
Sample preparation
The manufacturing process for granule products was
considered an industrial-scale reproduction of a water
decoction. In this study, 1 g of a ground raw herb sample
(30-mesh size) was refluxed in 30 mL of boiling water
three times for 30 min. The aqueous extracts were com-
bined then centrifuged at 672 × g for 5 min and evapo-
rated to dryness. Each aqueous raw herb extract and 1 g
of each granule sample was sonicated in 10 mL of metha-
nol for 30 min (done three times), followed by centrifuga-
tion at 672 × g for 5 min. The supernatants were collected
and evaporated to dryness at 60 °C under vacuum. This
procedure separated the water-soluble excipients from the
granule samples, and allowed for comparison of the two
products as methanol extracts (Additional file 3). The dry
residue was weighed and re-dissolved in a minimum
volume of methanol for further analysis.
Preparation of standard solutions
Stock standard solutions of the reference marker com-
pounds Rg1, Rg2, Rd, Rb1 and NR1 (2 mg/mL) were pre-
pared in methanol and stored at 4 °C. Working standard
solutions for calibration at five different concentrations
were freshly prepared by dilution of the stock solutions.
The concentration ranges of the calibration curves for
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Instrumentation and chromatographic conditions
TLC
ATLC kit (CAMAG Chemie-Erzeugnisse & Adsorptionstechnik
AG, Muttenz, Switzerland) containing a Linomat 5 auto-
matic applicator with 100-μL syringes and a software-
linked (winCATs ver.1.3.0 system) imaging device was
used for TLC. TLC plates were evaluated using a CAMAG
Scanner 3 with visible light, 366 nm light and 254 nm
light, and a camera (Canon PSG× digital camera). The
TLC plates were silica gel 60 F254 plate (20 cm× 20 cm)
(Merck KGaA, Darmstadt, Germany), and each plate was
cut into 10 cm × 10 cm squares before use. The application
position was 10 mm from the lower edge of the TLC plate.
All samples were applied according to the following set-
tings: 8-mm band width, 2-mm space between tracks, and
eight tracks on each plate. Standards and samples (6 μL)
were loaded onto the TLC plates. All remaining mea-
surement parameters were default settings. CAMAG
Twin Trough chambers (10 × 10 cm) with a stainless steel
lid were used for the development of the plates with a mo-
bile phase of chloroform–ethyl acetate–methanol–water
(15:40:22:9, v/v/v/v) as described previously [16]. The
chamber was kept in a fume hood at an ambient
temperature of 20 °C. The plate was developed vertically
from the lower edge to 80 mm. After development, the
plate was air-dried for 10 min before derivatisation. Ginse-
nosides have weak absorption at low UV wavelengths as
they do not possess a strong chromophore [17]. Therefore,
the plates were dipped into ice cold sulfuric acid (10 %
sulfuric acid in iced methanol) in a CAMAG chamber
tank. The plates were then air-dried for 10 min, and
heated at 100 °C in an oven for 5 min. The analytes were
quantified with the CAMAG Scanner 3 using a D2&W
lamp set at 366 nm, with 20-mm/s scanning speed. A
CAMAG Reprostar 3 with winCATs software was used to
analyse the derivatised plates.
UPLC–PDA
UPLC-PDA analyses were performed using a Waters
ACQUITY UPLC™ system (Waters, Milford, USA),
equipped with quaternary solvent manager (ACQ-QSM),
quaternary pump, sampler manager FTN (ACQ-FTN),
column compartment, PDA detector (ACQ-PDA), and
connected to Waters Empower 3 software. UPLC sepa-
rations were carried out using an Acquity UPLC BEH
C18 column (150 mm × 2.1 mm, 1.7 μm) with an at-
tached pre-column (2.1 mm × 5 mm, 1.7 μm) (Waters).
The column and sample temperature were kept at 20 °C
and 4 °C, respectively. The initial mobile phase consisted of
water (A)-acetonitrile (B) (82:18, v/v). Gradient conditions
were based on a modification of a method describedpreviously [18], with a gradient elution as follows: 0–
5.5 min, 18–19 % B; 5.5–6.0 min, 19–31 % B; 6.0–9.5 min,
31–35 % B; 9.5–12.0 min, 35–56 % B, 100 % B for 6 min.
The column was reconditioned isocratically with 18 % B
for 7 min. The flow rate was 0.30 mL min−1 and the in-
jection volume was 1 μL. The detection wavelength was
203 nm. All solutions were filtered using 0.2-μm polytetra-
fluoroethylene membrane filters before injection. The total
run time for the analysis was 25 min. The identification of
compounds in the samples was carried out by comparison
of UV spectra and retention times.
LC-MS
The purity of the references was verified by liquid
chromatography-mass spectrometry (LC-MS). LC-MS
experiments were performed on a Waters Acquity Xevo
TQ triple quadruple mass spectrometer coupled to a
binary pump, PDA detector and an autosampler (Waters,
Milford, USA). Mass spectra were acquired in negative
electrospray ionisation (ESI) mode with a mass range of
m/z 100–1200. The data were analysed by MassLynx Mass
Spectrometry software (Waters, Milford, USA).
Validation procedure
The TLC and UPLC methods were partially validated in
terms of linearity and repeatability. Six-point calibration
curves were constructed with linear ranges of 0.05–
1 mg/mL and 0.0125–1 mg/mL for TLC and UPLC, re-
spectively. Six replicates of the calibration standards
were prepared, and each was analysed in triplicate. Regres-
sion equations, y = ax + b, were calculated, where x and y
are the concentration of the reference samples and the peak
area, respectively. The LOD and LOQ were calculated ac-
cording to the equations, LOD= 3.33 × (standard deviation
[SD] of y-intercept/mean of slope) and LOQ= 10 × (SD of
y-intercept/mean of slope) [19]. The quantity of each ana-
lyte was obtained from the corresponding calibration
curve. The relative standard deviation (RSD) was used as
a measure of repeatability. The intra-day precision was
evaluated by analysing four concentrations of each marker
compound three times within a day, and the inter-day re-
producibility was examined on three consecutive days.
ABTS antioxidant assay
A modification of an established procedure [20] was
used to estimate the ABTS radical scavenging capacities
of the notoginseng extracts. The ABTS radical working
solution was prepared by mixing equal volumes of
7 mmol/L ABTS solution with 2.45 mmol/L potassium
persulfate solution, and the mixture was left in the dark
for 12 to 16 h at room temperature. On the day of ana-
lysis, the stock solution was diluted with PBS (pH 7.4)
until an initial absorbance value of 0.4 at 730 nm was
reached. Diluted ABTS (200 μL) was mixed with 20 μL
Table 1 The average yields of the raw herbs (R1-R6) and
granule (G1-G12) methanol extracts (n ≥ 3)
Samples Average yield (%) RSD (%)a
R1 24.17 8.65
R2 23.52 4.34
R3 23.26 0.13
R4 19.82 6.71
R5 15.150 1.06
R6 20.50 5.71
G1 3.59 11.75
G2 8.58 7.44
G3 9.17 13.02
G4 3.16 7.39
G5 3.12 22.98
G6 2.02 0.94
G7 12.47 3.37
G8 1.07 9.01
G9 7.62 6.83
G10 7.16 9.66
G11 11.54 9.79
G12 18.85 7.07
R raw herb; G granule
aRSD (%) = 100 × S.D./mean
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taken 5 min after mixing. Trolox (0.045–0.330 mmol/L)
was used as the standard. The antioxidant activity was
calculated as the concentration of ABTS + quenched by
1 mmol/L of Trolox. The antioxidant activities of the
notoginseng samples were expressed as Trolox equivalents
per dry weight (DW) of the sample (mmol L−1/g of DW)
[21]. The ABTS assay was performed in triplicate.
Statistical analysis
The results from the granules were converted back to raw
herb values, by the ratio specified on the product, to com-
pare the raw herb and granule products. Here, the residue
obtained from the granules after the methanol extraction
was assumed to be equivalent to the raw herb water extract
without excipients. The yields were expressed as the mean
± SD of three extractions. Each of the three extracts from
the same sample were analysed three times by TLC and
UPLC, with the final quantitative results from TLC and
UPLC instrumental analyses expressed as the mean ± SD.
Quantitative results were reported as milligrams per grams
of the DW of the raw herb (mg/g).
The TLC and UPLC quantitative data were analysed
non-parametrically by IBM SPSS Statistics 20 for Windows
(SPSS Inc., Chicago, IL, USA) to determine any significant
differences in the marker compound contents between the
raw herbs and granules. The compound(s) that showed sig-
nificant differences were assigned as variables for HCA.
The data were pretreated by autoscaling. HCA was con-
ducted by the Ward’s method and Euclidean distances.
The results were expressed as dendrograms where the
length of the branches between samples reflected the de-
gree of similarity between them.
PCA was conducted by XLSTAT (Addinsoft, New York,
USA). PCA converted the original variables (five marker
compounds) into a new set of linearly uncorrelated factors
(PCs). The first and second PCs corresponded to the lar-
gest possible variance of the original variables. The results
were represented in a biplot (score plot and loading plot),
which showed the distribution of the samples and the cor-
relation of the five original variables to the two PCs [8, 22].
The yield and ABTS results were analysed by indepen-
dent samples t-test and non-parametric analysis. Pearson
correlation coefficients (r) indicated the strength of the
correlation between the contents of the five marker
compounds in the samples and their ABTS scavenging
activities. These analyses were conducted by SPSS, and
P < 0.05 was considered statistically significant.
Results and discussion
Extraction yield
The average amount of dry residue obtained from each
sample is shown in Table 1. The average yields of the
raw herbs (R1–R6) were consistent at 21.07 ± 3.39 % ofthe dry weight of the herb. Independent samples t-tests
illustrated that, within the raw herb group, the yield
from R5 was significantly lower than those from the rest
of the raw herbs (P = 0.029). By contrast, the average
yields of the granule products were variable and ranged
from 1.07–18.85 %. The differences in the yield for the
granule products could be caused by the varied manu-
facturing processes used by the companies that pro-
duced the granules. For example, extraction procedures,
temperature conditions, the type and amount of excipi-
ents used, and other factors in the manufacturing pro-
cesses can affect the quality of the finished product. A
comparison of the two groups using non-parametric ana-
lysis showed that the yields from the raw herbs were sig-
nificantly higher than those from the granules (P = 0.000).
The excipients added to the granules during manufactu-
ring might be slightly soluble in methanol, and may have
affected the final calculation of the notoginseng content of
the granule product thus, giving a lower concentration for
the granule extract. The RSD yields for the raw herbs
ranged from 0.19–8.66 %, whereas the RSD yields for the
granules ranged from 0.95–23.014 %, indicating that the
granule particles were not uniform, even though every
granule bottle was shaken before sampling to redistribute
the particles.
Table 2 Regression data, detection/quantification limits and precision data for the five compounds determined by UPLC-PDA
Compounds Regression equation R2 LOD LOQ Precision, RSD (%) Precision, RSD (%)
(μg/mL) (μg/mL) Intra-day (n = 3) Inter-day (n = 3)
TLC* UPLC* TLC UPLC TLC UPLC TLC UPLC TLC UPLC TLC UPLC
NR1 y = 5752.1x + 796.27b y = 497892x + 1692a 0.993 0.994 16.60 3.77 49.80 11.30 3.17 1.95 1.04 4.59
Rb1 y = 15159x-498.43a y = 451285x-8794.1a 0.991 0.997 12.60 4.26 37.90 41.70 7.06 1.67 0.92 0.55
Rd y = 8877.8x + 1092.3b y = 502877x + 4048.3a 0.995 0.994 144.00 3.31 431.00 9.95 1.67 0.74 6.92 1.98
Rg1 y = 8095.7x + 1360.3a y = 519908x-3073.3a 0.992 0.993 126.00 16.20 378.00 48.80 2.23 3.58 4.68 2.82
Rg2 y = 11839x + 958.33a y = 529865x + 1901.5a 0.991 0.998 33.700 5.97 101.00 17.90 0.77 2.18 2.80 0.26
RSD (%) = 100 × S.D./mean; y, peak area; x, the concentration of each reference compound (mg/mL); R2, coefficient of determination; LOD, limit of detection
(3.33 × (SD of Y-intercept/mean of slope)); LOQ, limit of quantification (10 × (SD of Y-intercept/mean of slope))
an=3
bn=4
*All P values for the regression equations are = 0.000
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ginseng content on the product label. One company ex-
plained that this information was not provided on the
product label because it could vary from batch to batch.
This variation could arise from collecting starting mate-
rials from different sources. Differences in the raw herbs
would affect the amount of residue obtained after pro-
cessing and extraction. The non-standardised manufac-
turing processes for granule products could affect the
quality of the products and result in efficacy issues for
practitioners and consumers.Table 3 Contents (mg/g, mean ± SD, n = 3) of the five compounds
Sample NR1 Rb1 Rd
TLC UPLC TLC UPLC TLC
R1 31.77 ± 0.80 6.06 ± 0.97 24.54 ± 0.39 17.82 ± 1.38 3.35 ± 2.0
R2 41.64 ± 1.47 5.48 ± 1.16 27.38 ± 0.36 19.21 ± 2.37 8.36 ± 0.3
R3 35.64 ± 0.30 6.05 ± 0.92 31.91 ± 0.77 17.78 ± 0.78 5.94 ± 0.8
R4 27.15 ± 1.09 9.15 ± 0.23 18.23 ± 0.99 21.54 ± 0.23 11.84 ± 0
R5 8.47 ± 0.77 6.20 ± 0.55 6.56 ± 0.39 12.79 ± 0.38 ND
R6 3.03 ± 0.04 4.26 ± 0.05 3.73 ± 0.10 16.48 ± 0.77 2.77 ± 0.0
G1 2.21 ± 0.29 0.84 ± 0.16 2.93 ± 0.06 3.03 ± 0.23 2.17 ± 0.0
G2 3.77 ± 0.06 1.37 ± 0.04 4.49 ± 0.32 4.97 ± 0.14 1.20 ± 0.2
G3 9.46 ± 1.48 2.46 ± 0.03 7.34 ± 0.56 9.74 ± 0.09 3.03 ± 2.5
G4 0.86 ± 0.13 0.37 ± 0.01 1.24 ± 0.14 1.52 ± 0.09 1.28 ± 0.3
G5 0.40 ± 0.19 0.52 ± 0.01 1.11 ± 0.02 2.22 ± 0.01 0.02 ± 0.0
G6 2.51 ± 0.05 0.72 ± 0.01 1.40 ± 0.15 2.56 ± 0.02 0.64 ± 0.0
G7 11.96 ± 1.10 7.86 ± 0.41 16.59 ± 0.18 32.93 ± 2.01 8.57 ± 2.4
G8 0.02 ± 0.01 0.08 ± 0.00 0.36 ± 0.01 0.42 ± 0.02 0.35 ± 0.0
G9 5.39 ± 0.05 2.83 ± 0.07 5.31 ± 0.13 10.60 ± 0.43 3.24 ± 0.1
G10 5.81 ± 0.25 2.72 ± 0.36 5.59 ± 0.14 12.07 ± 0.95 1.48 ± 0.4
G11 12.28 ± 0.09 1.16 ± 0.19 11.22 ± 0.33 4.20 ± 0.62 1.26 ± 0.5
G12 11.72 ± 0.71 7.51 ± 0.42 12.67 ± 0.03 24.12 ± 0.15 7.58 ± 0.5
ND not detectedValidation of TLC and UPLC method
Calibration, linearity, LOQ and LOD
The linear regression equations, coefficient of determi-
nation (R2), limit of quantification (LOQ), limit of detection
(LOD), average intra- and inter-day repeatability (RSD) for
each standard were shown in Table 2. The R2 values were
greater than 0.991 for all the analytes (P values corres-
ponding to a R2 value of 0.000), showing good linearity for
the experimental data for both analytical methods. The
LODs for TLC and UPLC of the five marker compounds
ranged from 12.60–144.00 μg/mL and 3.31–16.20 μg/mL,in Sanqi samples analysed by TLC and UPLC-PDA
Rg1 Rg2
UPLC TLC UPLC TLC UPLC
7 4.02 ± 0.23 58.06 ± 0.57 38.70 ± 1.51 2.51 ± 0.45 1.83 ± 0.12
2 7.08 ± 1.54 41.78 ± 0.81 25.38 ± 2.34 4.59 ± 0.24 3.39 ± 0.77
8 6.82 ± 0.12 47.89 ± 1.41 33.87 ± 0.93 3.47 ± 0.34 2.56 ± 0.03
.65 6.95 ± 0.33 53.80 ± 2.65 39.68 ± 1.40 7.57 ± 0.10 2.30 ± 0.11
6.00 ± 0.41 45.35 ± 1.62 35.71 ± 0.73 ND 2.38 ± 0.25
6 6.90 ± 0.67 10.55 ± 0.19 23.63 ± 0.39 1.87 ± 0.07 3.59 ± 0.06
7 0.80 ± 0.03 4.14 ± 0.02 4.00 ± 0.34 0.63 ± 0.04 0.32 ± 0.00
6 2.06 ± 0.20 8.83 ± 0.40 5.15 ± 0.10 2.68 ± 0.16 2.72 ± 0.36
6 2.50 ± 0.06 12.79 ± 0.89 12.94 ± 0.14 1.56 ± 0.14 0.57 ± 0.00
3 0.38 ± 0.01 4.13 ± 0.48 2.14 ± 0.01 0.58 ± 0.03 0.09 ± 0.01
0 0.57 ± 0.01 2.13 ± 0.08 2.91 ± 0.04 0.27 ± 0.03 0.09 ± 0.01
4 0.93 ± 0.01 5.14 ± 0.02 3.27 ± 0.03 0.26 ± 0.05 0.19 ± 0.01
9 9.52 ± 1.53 27.73 ± 0.84 42.95 ± 2.73 3.11 ± 0.88 1.63 ± 0.24
1 0.07 ± 0.00 0.58 ± 0.01 0.52 ± 0.01 0.08 ± 0.01 0.08 ± 0.01
3 2.47 ± 0.40 13.58 ± 0.49 15.14 ± 0.59 1.55 ± 0.48 0.57 ± 0.09
1 2.94 ± 0.19 13.50 ± 0.08 15.73 ± 1.93 ND 0.52 ± 0.12
1 1.71 ± 0.57 19.67 ± 0.09 4.65 ± 0.90 ND 1.98 ± 0.03
4 7.28 ± 0.17 30.26 ± 0.95 34.88 ± 0.26 2.56 ± 0.08 1.23 ± 0.24
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five marker compounds were 37.90–378.00 and 9.95–
48.80 μg/mL, respectively. The LODs and LOQs from
UPLC were generally lower than those from TLC
(P = 0.016 and P = 0.032 for LOD and LOQ, respectively),
indicating higher sensitivity was achieved with the UPLC
method.
Precision
Good instrumental and method precision was obtained
for both UPLC and TLC. As shown in Table 2, the RSD
for the intra- and inter-day precision ranged from
0.768–7.059 % and 0.916–6.916 % for TLC. For UPLC,
the corresponding ranges were 0.739–3.579 % and
0.236–4.591 %, respectively.
Quantification by TLC
The resolution of TLC for the marker compound noto-
ginseng NR1 and ginsenoside Re was not sufficient to
quantify these compounds separately (Additional file 4).
As the content of Re in notoginseng is reportedly ap-
proximately half that of NR1 [23], the total NR1 + Re
peak was used for the quantification of NR1 in thisFig. 1 Chromatograms of five ginsenosides analysed by UPLC-PDA. a Raw
(4) Rg2 and (5) Rdstudy. The contents for the marker compounds detected
in the samples were shown in Table 3. The following
compounds were below the limit of quantification: Rg2
in samples R5, G10 and G11, and Rd in sample R5.
Fluorescence (UV 366 nm) was used for visualisation of
the derivatised saponins, and this enhanced their detec-
tion compared with the lower absorbance measurement
at 254 nm. However, the noise level also increased [17].
Although the TLC profiles of the raw herbs and granule
extracts were similar, the contents of the marker com-
pounds were much higher in the raw herbs than in the
granules, with the exception of G7 and G12.
Quantification by UPLC-PDA
Typical UPLC-PDA profiles of the raw notoginseng and
granule extracts were shown in Fig. 1. The contents of
the marker compounds in the samples were shown in
Table 3. After many UPLC runs, ginsenosides Re and
Rg1 could not be successfully separated. This was also a
problem in previous chromatography studies [24–27]. Ac-
cording to Wan et al. [28], the Rg1/Re ratio was 6.19 ± 0.82
in 18 samples of notoginseng from different origins. As
the content of Re is much smaller than that of Rg1 andherb extract (R6), b Granule extract (G12). (1) NR1, (2) Rg1, (3) Rb1,
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Re was used as the Rg1 content. The low standard devia-
tions of the five standards in the raw herbs and granules
showed good repeatability for the quantification (Table 3).
The contents of the marker compounds in the granules
were substantially lower than those in the raw herb sam-
ples, with the exception of G7 and G12. The contents of
each of the five compounds were not significantly different
within the raw herb samples and within the granule
products (P > 0.05). However, these two groups were
significantly different when the contents were compared
(P = 0.000). Differences in the contents of the marker
compounds in the granules might be related to the vari-
able yields (Table 1) and the different notoginseng con-
tents claimed by the manufacturers.
Differentiations of raw notoginseng and granules
The contents of the five marker compounds were used
in HCA analysis for grouping of similar products (Fig. 2),
and two groups were found. For TLC, the Cluster 1 in-
cluded samples R1 to R4, and the Cluster 2 included R5
and R6 and the granule products. The clustering of R5
and R6 by HCA with the granule products could have
arisen because the concentrations of some markerGCluster 1
Cluster 2 A
Fig. 2 HCA dendrograms of Sanqi extracts analysed by (a) TLC and (b) UPL
granule extracts into two main clusters, with raw herb samples R1 to R4 cla
with the granules (Cluster 2). b The HCA for UPLC grouped granule sample
granules in Group 2compounds in these samples were too low for TLC
quantification.
For UPLC, HCA showed a similar pattern, and sam-
ples G7 and G12 were grouped with the raw herbs
(Group 1) and the rest of the granules as Group 2.
PCA was also applied to differentiate samples by dis-
playing them as coordinates in maps based on the con-
tents of the five marker compounds. In the PCA biplot,
each point represents an individual sample and the red
line represents the contribution of each original variable
to the score of two major PCs (Fig. 3). For TLC, PC1
represented up to 82.73 % of the total variance and PC2
(10.64 %) cumulatively explained up to 93.37 % of total
variance. The distribution of the samples based on PC1
was due to the variance from all the markers com-
pounds, while the separation of samples by PC2 was
based on the contents of Rd and Rg2. The TLC biplot
differentiated the raw herbs and granules. Samples R1 to
R4 (Cluster 1) showed higher contents of all the marker
compounds than the other samples. In particular, R4
had the highest contents of Rd and Rg2. Samples R5 and
R6 were plotted close to the granules (Cluster 2).
For UPLC, the biplot showed that PC1 (84.77 %) and
PC2 (11.46 %) cumulatively explained up to 96.23 % ofroup 1
Group 2 B
C. a HCA dendrograms for the TLC results divided the raw herb and
ssified into one cluster (Cluster 1), whereas R5 and R6 were grouped
s G7 and G12 with the raw herb cluster (Group 1), with the rest of the
Cluster 2 Group 2 
Group 1
Cluster 1
A B
Fig. 3 PCA biplot (loading and score plot) of Sanqi raw herb and granule extracts analysed by (a) TLC and (b) UPLC. a From the TLC biplot, R1 to
R4 demonstrated a higher amount of the compounds (Cluster 1), especially R4 (highest amount of Rd and Rg2). R5 and R6 were closely distributed
with the granules (Cluster 2). b For UPLC, Group 1 containing the raw herbs, G7 and G12 which possessed higher amounts of the five compounds,
whilst Group 2 contained the rest of the granules
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ginal variables, and PC2 was mainly related to Rg2.
Based on the two PCs, the PCA biplots for the UPLC
results divided the samples into two groups: Group 1
contained the raw herbs and G7 and G12 of the granule
products, whilst Group 2 contained the rest of the
granule products. This agreed with the UPLC HCA results.
Current pharmacopoeia standards for notoginseng
In the PPRC, ginsenosides Rg1, Rb1 and notoginseng NR1
are recommended for the quality assessment of the raw
herb [29]. The total ginsenosides content (i.e., NR1 +Rg1 +
Rb1) in the root and rhizome of notoginseng (methanol
extract) should not be less than 5.0 %. However, this
guideline does not apply to granules [29]. From the TLC
calculations (Table 4), all the raw herb samples (R1–R6)
met this minimum requirement, with the total ginseno-
sides content ranging from 6.0 % to 11.5 %. By contrast,Table 4 Pearson correlation between the contents of the
compounds analysed by UPLC and the anti-oxidant capacity of
the extracts
Components ABTS
Rg2 0.740a
Rd 0.836a
Rb1 0.772a
NR1 0.769a
Rg1 0.768a
aCorrelation is significant at the 0.01 level (2-tailed)the total ginsenosides content in most of the granules was
less than 5.0 % (range 0.1 % to 4.3 %). In the granules, the
contents of G7 and G12 were high at 5.6 % and 5.5 %,
respectively.
From the UPLC data (Table 3), the raw herb samples
(R1–R5) met the minimum requirement of PPRC, with
total ginsenosides contents ranging from 5.0 % to 8.2 %.
Only sample R6 had a relatively low total ginsenosides
content (4.4 %). As with the TLC results, most of the
granules contained less than 5.0 % of these three marker
compounds, with total ginsenosides contents ranging
from 0.1 % to 3.1 %. Again, the contents of G7 and G12
were high at 8.4 % and 6.7 %, respectively. Due to the
content differences between raw notoginseng and gran-
ules, standards for the granules need to be established
and included in future editions of the PPRC.
For comparative purposes, HCA was conducted using
the contents of the three marker compounds (NR1, Rg1
and Rb1) specified by the PPRC [29]. From the TLC re-
sults, HCA produced clusters that were identical to
those derived when using the contents of all five marker
compounds studied. However, for the UPLC results, R2
and R6 were grouped with the granules, compared to
Group 1 which included all the raw herbs plus G7 and
G12 (Additional file 5). These results suggest that more
marker compounds (i.e., five rather than three) are re-
quired to differentiate raw notoginseng from granule
products [29]. A similar finding was reported for the
roots of Pueraria lobata and P. thomsonii and their
granule products [30].
Fig. 4 ABTS activity of Sanqi raw herb and granule extracts (n ≥ 3). Generally, raw herb samples (12.68 – 31.41 mM/g DW) showed a higher ABTS
radical scavenging activity than granule samples (1.41 – 21.13 mM/g DW). R6 exhibited the highest anti-oxidant activity among all the samples
(31.41 mM/g DW). For the granule samples, G7 and G12 possessed strong radical scavenging activity (21.13 and 15.28 mM/g DW, respectively)
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The ABTS assay was conducted at both 730 nm and
410 nm for comparison with the literature, and both wave-
lengths gave similar results (Fig. 4). The results for the
ABTS assay at 730 nm are reported here, as the values are
reported as Trolox equivalents and this is measured at
730 nm. R6 exhibited the highest antioxidant activity
among all the samples (31.41 mmol L−1/g DW). For the
granules, both G7 and G12 showed strong radical sca-
venging activity (21.13 and 15.28 mmol L−1/g DW,
respectively). Non-parametric analysis showed that the
antioxidant capacities of G7 and G12 were similar to
R1–R6 (Group 1) (P > 0.05). The ABTS radical scavenging
activity of Group 1 was significantly higher than that of
Group 2 (P = 0.005). Pearson correlation was performed to
examine the relationship between the quantitative data and
radical scavenging capacities. There were significant corre-
lations between the UPLC results for the marker contents
and the corresponding antioxidant activities (Table 4).
Conclusion
UPLC was more efficient than TLC for the simultaneous
determination of the five major compounds in Sanqi
products in terms of linearity, higher sensitivity and re-
peatability. The statistical analysis of the samples by HCA
and PCA revealed that contents of the marker compounds
were significantly higher in the raw herb group than the
granule group.
Additional files
Additional file 1: Chemical structures of the compounds assessed
in the Sanqi samples. Glc: β-D-glucose; rha: α-L-rhamnose; xyl:
β-D-xylose [22].Additional file 2: Information for Sanqi raw herbs and granule
samples. Sanqi raw herbs were collected from six different sources in
China and twelve herbal granule products were purchased from China,
Taiwan and Australia.
Additional file 3: TLC of methanol extract and residue from the raw
herb/granule. Lane 1: Methanol extract of granule sample 4 (G4); Lane 2:
Residue of the methanol extract of G4; Lane 3: Water and methanol
extract of the raw herb R1; Lane 4: Residue of water and methanol
extract of raw herb. As shown in the figure, Lanes 1 and 3 of the
methanol extract contain many bands which represented the marker
compounds, whereas Lanes 2 and 4 were absent of the bands. This
supported the assumption that methanol efficiently extracted the major
compounds.
Additional file 4: TLC fluorescence image of Sanqi raw herb and
granule samples with the standards under UV mode (366 nm). Key:
Lane 1 – Notoginseng NR1; Lane 2 – Ginsenoside Re; Lane 3 – Ginsenoside
Rg1; Lane 4 - R6 methanol extract; Lane 5 - G12 methanol extract; Lane
6 -Ginsenoside Rg2; Lane 7 – Ginsenoside Rd; Lane 8– Ginsenoside Rb1.
Additional file 5: HCA dendograms of Sanqi extracts analysed by
(A) TLC and (B) UPLC results using three markers (NR1, Rg1 and
Rb1). For TLC, HCA revealed that the clusters were identical to those
derived from the content of the five marker compounds. However, for the
HCA result analysed by UPLC, R2 and R6 were grouped with the granules.
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